Meeting
2023 ASCO Annual Meeting
Expression molecular subtype as a predictor of outcomes of chemoradiotherapy for esophageal cancer.
Authors
Manabu Muto
Department of Therapeutic Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Manabu Muto , Keiko Minashi , Tomonori Yano , Yusuke Amanuma , Ryu Ishihara , Akinori Watanabe , Chikatoshi Katada , Tomoki Yamatsuji , Kayoko Matsushima , Hisashi Doyama , Takayuki Ando , Yasumasa Nishimura , Katsuyuki Sakanaka , Shigeru Tsunoda , Shinya Ohashi , Juko Shimizu , Harue Tada , Ryuji Uozumi , Kengo Nagashima , Hiroki Sasaki
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer - Advanced/Metastatic Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 4030)
DOI
10.1200/JCO.2023.41.16_suppl.4030
Abstract #
4030
Poster Bd #
351
Abstract Disclosures
Similar Posters
Poster
2018 Gastrointestinal Cancers Symposium
Nonoperative management of locally advanced esophageal and junctional (GEJ) cancers: The University of Rochester experience.
First Author: Rachel Julie David
Poster
2013 Gastrointestinal Cancers Symposium
Survival in patients with esophageal cancer treated with surgery after chemoradiotherapy.
First Author: Ravi Shridhar
Poster
2012 Gastrointestinal Cancers Symposium
Effect of increased time from chemoradiation to surgery on the pathologic complete response rate in patients with esophageal cancer.
First Author: Talha Shaikh
Poster
2012 Gastrointestinal Cancers Symposium
Outcome of trimodality-eligible esophagogastric cancer (EC) patients who declined surgery after preoperative chemoradiation.
First Author: Takashi Taketa